China is expected to become even more central to our business in the coming years, because it sparks additional opportunities for cooperation and because it is…
In Conversation
it is evident that patient needs are really driving what is happening in the medical device industry today
All of our staff serving the Taiwanese market are based in Taiwan, and this demonstrates our commitment to the market
Once a country has critical mass, then our ambition changes from having a country partner to establishing our own operations there
A collaboration of multidisciplinary stakeholders from the public and private sectors is needed to improve access and adoption of innovative medicines
[Allergan] is at once a pharma company, a medical device company, a cosmetics/aesthetics company and a digital company
Around 20 percent of Janssen's global clinical trials have Nordic sites, with approximately 40 ongoing studies in Sweden
We are focused on developing and constructing medical theories of hypoxia and producing medical products and services for this field.
JCA’s agility and elasticity has allowed us to successfully help our customers consistently succeed.
To me, patient-centricity means we put the patients at the heart of everything we do. Our ultimate goal is to make sure each patient has the…
For biotech companies, the costs involved in IPO on TPEx is more realistic than those on other major international markets. Besides, TPEx listing requirements for biotech…
Sweden is sitting on a wealth of health data contained in its national quality registries which provide a unique source of real-world evidence. We act as…
